RV2666C Formula LA2984
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RV2666C Formula LA2984, covering 2025-09-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype